|
MED10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.516600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.465000E-01 |
| Normal-vs-Stage2 |
4.682800E-01 |
| Normal-vs-Stage3 |
8.046400E-01 |
| Normal-vs-Stage4 |
2.447600E-01 |
| Stage1-vs-Stage2 |
9.258000E-01 |
| Stage1-vs-Stage3 |
2.669400E-01 |
| Stage1-vs-Stage4 |
6.391800E-01 |
| Stage2-vs-Stage3 |
4.326000E-01 |
| Stage2-vs-Stage4 |
7.962200E-01 |
| Stage3-vs-Stage4 |
2.304000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.820620E-01 |
| Normal-vs-AfricanAmerican |
7.751800E-02 |
| Normal-vs-Asian |
5.408200E-01 |
| Caucasian-vs-AfricanAmerican |
2.566400E-01 |
| Caucasian-vs-Asian |
1.395410E-01 |
| AfricanAmerican-vs-Asian |
4.237700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.891600E-01 |
| Normal-vs-Female |
1.881010E-01 |
| Male-vs-Female |
1.078560E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.174970E-01 |
| Normal-vs-Age(41-60Yrs) |
4.693600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.526800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.084600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.772800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.403000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.456190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.096000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.766160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.853760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.874240E-01 |
| Classical-VS-Follicular |
4.934200E-01 |
| Classical-VS-Other |
9.285800E-01 |
| Classical-VS-Normal |
4.968000E-01 |
| Tall-VS-Follicular |
1.067550E-01 |
| Tall-VS-Other |
4.736600E-01 |
| Tall-VS-Normal |
9.385900E-02 |
| Follicular-VS-Other |
8.854000E-01 |
| Follicular-VS-Normal |
8.531800E-01 |
| Other-VS-Normal |
9.292400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.628600E-01 |
| Normal-vs-N1 |
2.345400E-01 |
| N0-vs-N1 |
2.821400E-01 |
|
|
